Key research implications include: Glycemic durability: Long-term HbA1c reductions without compensatory hyperglycemia Cardiovascular signaling: Improved lipid profiles and blood pressure suggest systemic metabolic benefits High-risk subgroups: Differential responses in high-BMI and insulin-resistant populations provide insight into personalized metabolic research strategies Collectively, Phase 3 data position retatrutide as a critical tool for exploring glucagon signaling beyond its classical role in glucose regulation
References Lehmann EW, Torekov SS
Glucagon-like peptide-1 and its receptor agonist exendin-4 modulate cholangiocyte adaptive response to cholestasis
There is no obligation to commence treatment following this
Khunti K, Nikolajsen A, Thorsted BL, Andersen M, Davies MJ, Paul SK
Be watchful of symptoms like severe stomach pain, signs of pancreatitis (such as severe upper abdominal pain that may radiate to the back, along with nausea, vomiting, or fever), or allergic reactions, and consult a doctor immediately if they occur